Unknown

Dataset Information

0

Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export.


ABSTRACT: Type I interferon (IFN) inhibits virus replication by activating multiple antiviral mechanisms and pathways. It has long been recognized that type I IFNs can potently block HIV-1 replication in vitro; as such, HIV-1 has been used as a system to identify and characterize IFN-induced antiviral proteins responsible for this block. IFN-induced HERC5 contains an amino-terminal Regulator of Chromosome Condensation 1 (RCC1)-like domain and a carboxyl-terminal Homologous to the E6-AP Carboxyl Terminus (HECT) domain. HERC5 is the main cellular E3 ligase that conjugates the IFN-induced protein ISG15 to proteins. This E3 ligase activity was previously shown to inhibit the replication of evolutionarily diverse viruses, including HIV-1. The contribution of the RCC1-like domain to the antiviral activity of HERC5 was previously unknown.In this study, we showed that HERC5 inhibits HIV-1 particle production by a second distinct mechanism that targets the nuclear export of Rev/RRE-dependent RNA. Unexpectedly, the E3 ligase activity of HERC5 was not required for this inhibition. Instead, this activity required the amino-terminal RCC1-like domain of HERC5. Inhibition correlated with a reduction in intracellular RanGTP protein levels and/or the ability of RanGTP to interact with RanBP1. Inhibition also correlated with altered subcellular localization of HIV-1 Rev. In addition, we demonstrated that positive evolutionary selection is operating on HERC5. We identified a region in the RCC1-like domain that exhibits an exceptionally high probability of having evolved under positive selection and showed that this region is required for HERC5-mediated inhibition of nuclear export.We have identified a second distinct mechanism by which HERC5 inhibits HIV-1 replication and demonstrate that HERC5 is evolving under strong positive selection. Together, our findings contribute to a growing body of evidence suggesting that HERC5 is a novel host restriction factor.

SUBMITTER: Woods MW 

PROVIDER: S-EPMC4021598 | biostudies-other | 2014 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export.

Woods Matthew William MW   Tong Jessica Gayle JG   Tom Sean Kevin SK   Szabo Peter Anthony PA   Cavanagh Peter Craig PC   Dikeakos Jimmy Dimitrios JD   Haeryfar S M Mansour SM   Barr Stephen Dominic SD  

Retrovirology 20140403


<h4>Background</h4>Type I interferon (IFN) inhibits virus replication by activating multiple antiviral mechanisms and pathways. It has long been recognized that type I IFNs can potently block HIV-1 replication in vitro; as such, HIV-1 has been used as a system to identify and characterize IFN-induced antiviral proteins responsible for this block. IFN-induced HERC5 contains an amino-terminal Regulator of Chromosome Condensation 1 (RCC1)-like domain and a carboxyl-terminal Homologous to the E6-AP  ...[more]

Similar Datasets

| S-EPMC2811201 | biostudies-literature
| S-EPMC3219974 | biostudies-literature
| S-EPMC2865908 | biostudies-literature
| S-EPMC5161282 | biostudies-literature
| S-EPMC2279259 | biostudies-literature
| S-EPMC7088374 | biostudies-literature
| S-EPMC4142337 | biostudies-literature
| S-EPMC1449526 | biostudies-literature
| S-EPMC1950902 | biostudies-literature
| S-EPMC8262885 | biostudies-literature